稳定性冠心病诊疗中患者参与临床决策质量及其影响因素

doi:10.16352/j.issn.1001-6325.2022.10.1572

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (10): 1572-1576.doi: 10.16352/j.issn.1001-6325.2022.10.1572

稳定性冠心病诊疗中患者参与临床决策质量及其影响因素

高川¹, 周俞余¹, 高莹^2*, 何仲^1*

1.中国医学科学院北京协和医学院人文和社会科学学院, 北京 100005;
2.中国医学科学院北京协和医学院国家心血管病中心阜外医院心内科, 北京 100037

收稿日期:2021-11-12 修回日期:2022-04-12 出版日期:2022-10-05 发布日期:2022-09-23
通讯作者: * cmuxyg@sina.com;hezhong08@126.com
基金资助:
师生心理健康与人际沟通能力建设研究(WH10022021064)

Quality and influencing factors of patient involvement in clinical decision-making in diagnosis and treatment of stable coronary artery disease

GAO Chuan¹, ZHOU Yu-yu¹, GAO Ying^2*, HE Zhong^1*

1. School of Humanities and Social Sciences, CAMS & PUMC, Beijing 100005;
2. Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, CAMS & PUMC, Beijing 100037,China

Received:2021-11-12 Revised:2022-04-12 Online:2022-10-05 Published:2022-09-23
Contact: * cmuxyg@sina.com;hezhong08@126.com

摘要/Abstract

摘要： 目的了解在稳定性冠心病(SCAD)的诊疗中,患者参与临床决策质量和决策偏好,并分析决策质量的影响因素。方法用便利抽样的方法,在阜外医院住院患者中抽取126例患者,调查患者的决策质量和决策偏好。利用单因素分析和二元Logistic回归分析患者决策质量的影响因素。结果 126例患者中,医疗决策偏好患者主导型50(39.7%)例,共同决策型26(20.6%)例,医生主导型50(39.7%)例,决策质量平均得分为81.39。单因素分析显示患者的家庭年收入、治疗满意程度和决策偏好是决策质量的影响因素(P＜0.05)。Logistic回归分析发现,治疗满意程度高(OR=6.722,95% CI:2.635~17.148)、共同决策偏好(OR=5.152,95% CI:1.477~17.975)的患者决策质量更高。结论在SCAD的诊疗中,从患者层面而言,合作型的决策偏好会提高决策质量,并提高治疗满意度。患者本身的因素不会影响决策质量,提升决策质量需要从医生和医院入手。

关键词: 稳定性冠心病, 医患共同决策, 决策偏好, 决策质量

Abstract: Objective To investigate the quality of patient participation in clinical decision-making and the decision preference of patients in the diagnosis and treatment of stable coronary artery disease(SCAD)and to analyze the influencing factors of decision quality. Methods A total of 126 inpatients in Fuwai Hospital were selected by convenience sampling to investigate their decision quality and decision preference. Univariate analysis and binary logistic regression were used to analyze the influencing factors of decision quality. Results Among 126 patients, 50(39.7%) were active, 26(20.6%) were shared and 50(39.7%) were not active. The average score of decision quality was 81.39. Univariate analysis showed that annual household income, treatment satisfaction and decision preference were the influencing factors of decision quality (P＜0.05). Logistic regression analysis showed that patients with high treatment satisfaction (OR=6.722, 95% CI:2.635-17.148) and shared decision preference (OR=5.152, 95% CI:1.477-17.975) had higher decision quality. Conclusions In the diagnosis and treatment of SCAD, shared decision preference can improve decision quality and improve satisfaction. The characteristics of patients are not related to decision quality. To improve the decision quality needs to start with doctors and hospital.

Key words: stable coronary artery disease, shared decision making, decision preference, decision quality

中图分类号:

R541

高川, 周俞余, 高莹, 何仲. 稳定性冠心病诊疗中患者参与临床决策质量及其影响因素[J]. 基础医学与临床, 2022, 42(10): 1572-1576.

GAO Chuan, ZHOU Yu-yu, GAO Ying, HE Zhong. Quality and influencing factors of patient involvement in clinical decision-making in diagnosis and treatment of stable coronary artery disease[J]. Basic & Clinical Medicine, 2022, 42(10): 1572-1576.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2022.10.1572

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2022/V42/I10/1572

参考文献 12

[1]	中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46: 680-694.
[2]	黄榕翀, 丁怀玉, 郭宏洲. 医患共同决策模式在我国临床实践中的应用与改进[J]. 中华心血管病杂志, 2020, 48: 890-894.
[3]	Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process[J]. BMJ, 2017, 359: j4891. doi: 10.1136/bmj.j4891.
[4]	Bruera E, Sweeney C, Calder K, et al. Patient prefer-ences versus physician perceptions of treatment decisions in cancer care[J]. J Clin Oncol, 2001, 19: 2883-2885.
[5]	Kriston L, Scholl I, Holzel L, et al. The 9-item shared decision making questionnaire (SDM-Q-9). development and psychometric properties in a primary care sample[J]. Patient Educ Couns, 2010, 80: 94-99.
[6]	罗碧华, 肖水源. 中文版医患共同决策问卷患者版的信效度[J]. 中南大学学报(医学版), 2019, 44: 823-829.
[7]	刘金涛, 杜昕, 马长生, 等. 心血管疾病患者参与临床决策倾向性的影响因素研究[J]. 中国医药, 2014, 9: 293-297.
[8]	郭旭芳, 刘欢, 吴丽萍, 等. 多囊卵巢综合征患者参与决策的影响因素研究[J]. 中国全科医学, 2021, 24: 2685-2690.
[9]	Doherr H, Christalle E, Kriston L, et al. Use of the 9-item shared decision making questionnaire (SDM-Q-9 and SDM-Q-Doc) in intervention studies-a systematic review[J]. PLoS One. 2017, 12: e0173904. doi: 10.1371/journal.pone.0173904.
[10]	陈化, 刘俊荣. 从知情同意到共同决策:临床决策伦理的范式转移——从Montgomery案例切入[J]. 医学与哲学(A), 2017, 38: 16-19.
[11]	夏文芳. 医患共同决策临床实效的影响因素分析[J]. 医学与哲学, 2021, 42: 11-14.
[12]	Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions[J]. Cochrane Database Syst Rev, 2017, 4: CD001431. doi: 10.1002/14651858.CD001431.pub5.

[1]	樊佳赛, 杜艺菲, 许佳颖, 陈思臻, 高永桧, 任景怡. 基于中医证候和机器学习构建慢性心力衰竭中西医结合预后模型[J]. 基础医学与临床, 2022, 42(8): 1169-1175.
[2]	赵茂宇, 李佑美, 刘焕云, 毛琦. 胰岛素抵抗标志物在动脉粥样硬化发病中的研究进展[J]. 基础医学与临床, 2022, 42(8): 1302-1305.
[3]	王振花, 李潮生. 饮食作用的肠道菌群-免疫轴与高血压相关性的研究进展[J]. 基础医学与临床, 2022, 42(6): 983-987.
[4]	何丹, 阮中宝. 细胞外囊泡在心房颤动发病中的作用[J]. 基础医学与临床, 2022, 42(4): 671-674.
[5]	王帅, 王建军, 孙秀红, 邬鹏宇, 崔志成, 李占清. 萝卜硫素减轻心脏移植模型大鼠缺血/再灌注损伤[J]. 基础医学与临床, 2022, 42(3): 411-416.
[6]	张爽, 李之凡, 钱杰, 吴娜琼. 腔内影像学方法评价降脂治疗对冠状动脉粥样硬化斑块影响的研究进展[J]. 基础医学与临床, 2022, 42(3): 366-371.
[7]	刘峰宇, 韩薇. 心肌细胞钙稳态失调在心力衰竭中作用的研究进展[J]. 基础医学与临床, 2022, 42(3): 502-506.
[8]	蒙颖, 张正义, 赵嫄, 卢昌宏, 商波, 孙鹏飞, 张德奎. X线放射诱导大鼠心肌细胞系H9c2损伤中组蛋白乙酰化水平降低[J]. 基础医学与临床, 2021, 41(8): 1139-1143.
[9]	王丽, 庞俊, 陈庆伟, 李桂琼, 柯大智, 李兴升. Ghrelin改善ApoE^-/-小鼠心肌梗死后内皮功能和斑块稳定性[J]. 基础医学与临床, 2021, 41(7): 935-940.
[10]	王放, 董哲, 孙艺红, 任景怡, 李菁, 周益锋, 郑金刚. 影响非缺血性心力衰竭患者心肌纤维化的因素分析[J]. 基础医学与临床, 2021, 41(3): 346-351.
[11]	庄红, 张苏川, 刘慧地, 徐亚宁, 黄璐, 代天, 蒋品. 沉默CXCL12抑制ox-LDL诱导小鼠巨噬细胞系RAW264.7泡沫化和凋亡[J]. 基础医学与临床, 2021, 41(2): 219-224.
[12]	秦桃, 李青, 李菊香. 成纤维细胞生长因子同源因子1在心律失常发病机制中的研究进展[J]. 基础医学与临床, 2020, 40(12): 1697-1700.
[13]	杨玲, 杜雪平. 北京市西城区急性冠脉综合征住院患者的诊断治疗分析[J]. 基础医学与临床, 2020, 40(12): 1681-1685.
[14]	郭方君, 杨人强. 血小板微粒促进动脉粥样硬化发生的研究进展[J]. 基础医学与临床, 2020, 40(11): 1551-1555.
[15]	冯冬萍, 商汉桥, 杨航, 张虎军, 张停, 杨梦溪, 屠强, 任景怡. 斑马鱼cetp基因敲除模型的建立及其肝脏转录组学分析[J]. 基础医学与临床, 2020, 40(7): 940-947.

稳定性冠心病诊疗中患者参与临床决策质量及其影响因素

Quality and influencing factors of patient involvement in clinical decision-making in diagnosis and treatment of stable coronary artery disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 12

相关文章 15

编辑推荐

Metrics

本文评价